4//SEC Filing
BUNKA CHRISTOPHER 4
Accession 0001348362-25-000010
CIK 0001348362other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:39 PM ET
Size
14.0 KB
Accession
0001348362-25-000010
Insider Transaction Report
Form 4
BUNKA CHRISTOPHER
DirectorChariman/CEO/President/CFO
Transactions
- Award
Stock Options
2025-05-15+11,000→ 184,834 totalExercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (11,000 underlying)
Holdings
- 373,543
common shares
- 254,412(indirect: Private Holding Company)
common shares
- 26,000
Stock Options
Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (26,000 underlying) - 49,334
Stock Options
Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (23,334 underlying) - 64,334
Stock Options
Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (15,000 underlying) - 94,334
Stock Options
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (30,000 underlying) - 124,334
Stock Options
Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (30,000 underlying) - 173,834
Stock Options
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (49,500 underlying)
Footnotes (1)
- [F1]100,000 common shares were issued as a restricted stock award that is subject to escrow provisions until July 7, 2025.
Documents
Issuer
Lexaria Bioscience Corp.
CIK 0001348362
Entity typeother
Related Parties
1- filerCIK 0001103780
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 5:39 PM ET
- Size
- 14.0 KB